Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Cannabist Company Holdingsinc

Start price
Target price
Perf. (%)
€0.86
29.09.23
-
29.09.24
-66.04%
02.05.24

buy
Vertiv Holdings Co.

Start price
Target price
Perf. (%)
€34.20
26.09.23
-
26.09.24
151.45%
02.05.24

buy
Cliq Digital AG

Start price
Target price
Perf. (%)
€20.50
23.09.23
-
23.09.24
-20.08%
02.05.24

buy
Super League Enterprise Inc.

Start price
Target price
Perf. (%)
€2.48
22.09.23
-
22.09.24
-
12.09.23

buy
Precision BioSciences Inc

Start price
Target price
Perf. (%)
€0.39
19.09.23
€2.81
19.09.24
-11.92%
13.02.24

buy
Innocan Pharma Corp.

Start price
Target price
Perf. (%)
€0.26
18.09.23
€1.00
18.09.24
-27.01%
02.05.24

Differentiated customer and product portfolio
Leading role in innovation
Revenue growth > 30% per year expected
Higher risks for its business
buy
Dianthus Therapeutics Inc.

Start price
Target price
Perf. (%)
€11.14
16.09.23
-
16.09.24
83.12%
24.04.24

buy
Novo-nordisk As

Start price
Target price
Perf. (%)
€91.56
15.09.23
-
15.09.24
33.46%
02.05.24

buy
Novo-nordisk As

Start price
Target price
Perf. (%)
€91.56
15.09.23
-
15.09.24
33.46%
02.05.24

buy
Columbia Care Inc.

Start price
Target price
Perf. (%)
€1.05
09.09.23
€1.30
09.09.24
14.29%
20.11.23

Capable Management
Innovative
Bad rating
Few uniques
buy
Traction Uranium Corp.

Start price
Target price
Perf. (%)
€0.25
01.09.23
€1.00
01.09.24
-81.67%
02.05.24

Could be very worthwhile Investment >20% year
Future proof or reliable business model
buy
Groupon Inc.

Start price
Target price
Perf. (%)
€11.00
29.08.23
-
29.08.24
-4.41%
02.05.24

Sensei Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€0.93
26.08.23
€0.50
26.08.24
67.93%
02.05.24

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Decining EBIT margin than peer group
Phunware Inc.

Start price
Target price
Perf. (%)
€0.28
26.08.23
€0.10
26.08.24
-43.93%
26.02.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Vidac Pharma Holding Plc

Start price
Target price
Perf. (%)
€1.30
26.08.23
€2.00
26.08.24
-83.23%
30.04.24

buy
Exasol AG

Start price
Target price
Perf. (%)
€2.67
23.08.23
-
23.08.24
-10.11%
02.05.24

Pacifico Renewables Yield AG

Start price
Target price
Perf. (%)
€28.80
22.08.23
-
22.08.24
9.72%
16.04.24

Boss Energy Ltd.

Start price
Target price
Perf. (%)
€1.88
16.08.23
-
16.08.26
59.40%
02.05.24

Could be very worthwhile Investment >20% year
buy
Katek SE

Start price
Target price
Perf. (%)
€14.05
11.08.23
€20.00
11.09.24
7.12%
02.05.24

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
Very capable Management
Medium risks for its business
buy
Personalis Inc

Start price
Target price
Perf. (%)
€1.80
10.08.23
€6.35
10.08.24
-31.01%
02.05.24

buy
Stoke Therapeutics Inc

Start price
Target price
Perf. (%)
€4.88
08.08.23
€21.00
08.08.24
111.07%
29.04.24

buy
Hims & Hers Health Inc.

Start price
Target price
Perf. (%)
€8.24
08.08.23
€12.78
08.08.24
38.65%
02.05.24

buy
Stoke Therapeutics Inc

Start price
Target price
Perf. (%)
€4.88
08.08.23
€31.98
08.08.24
111.07%
29.04.24

buy
Stoke Therapeutics Inc

Start price
Target price
Perf. (%)
€5.20
07.08.23
€22.72
07.08.24
109.62%
29.04.24

buy
Precision BioSciences Inc

Start price
Target price
Perf. (%)
€0.48
07.08.23
-
07.08.24
-28.10%
13.02.24